GGrantIndex
Sort

46,585 grants matching heart failure

Mitochondrial Integrated Stress Response in Neurological Diseases

$1,101,750
Giovanni Manfredi · Weill Medical Coll Of Cornell Univ · R35 · FY2022 · NS

Mitochondrial Integrated Stress Response in Neurological Diseases

$1,101,750
Giovanni Manfredi · Weill Medical Coll Of Cornell Univ · R35 · FY2025 · NS

Mitochondrial Integrated Stress Response in Neurological Diseases

$1,101,748
Giovanni Manfredi · Weill Medical Coll Of Cornell Univ · R35 · FY2023 · NS

Biobehavioral Studies of Obesity, Weight loss and Recidivism

$1,101,176
Monica Skarulis · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK

Clinical Center for LookAHEAD: Action for Health in Diabetes

$1,101,147
Cora E Lewis · University Of Alabama At Birmingham · U01 · FY2008 · DK

Molecular Studies of Eukaryotic Gene Regulation

$1,100,136
Bruce Paterson · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Cardiovascular Engineering Science

$1,099,215
Shu Chien · University Of California, San Diego · T32 · FY2008 · HL

Look AHEAD: Action for Health in Diabetes

$1,098,733
James O Hill · University Of Colorado Denver · U01 · FY2012 · DK

Safety and Efficacy of Sertraline for Depression CHF

$1,098,074
Ranga R Krishnan · Duke University · R01 · FY2006 · MH

Look AHEAD: Action for Health in Diabetes

$1,097,812
Frederick L Brancati · Johns Hopkins University · U01 · FY2009 · DK

Hispanic Community Health Study

$1,097,522
Gregory Talavera · San Diego State University · N01 · FY2011 · HL

Safety and Efficacy of Sertraline for Depression CHF

$1,097,250
Duke University · R01 · FY2003 · MH

Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies

$1,096,673
Harry L Malech · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Immunopathogenesis of Chronic Allograft Rejection

$1,096,213
Children'S Hospital Boston · P01 · FY2002 · AI

Look AHEAD: Action for Health in Diabetes

$1,096,014
Mark Andrew Espeland · Wake Forest University Health Sciences · U01 · FY2012 · DK

iPS-technology and patient specific disease models

$1,095,795
Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Anastrozole in Pulmonary Arterial Hypertension (AIPH2) - CCC (Lead)

$1,094,913
Steven M Kawut · University Of Pennsylvania · R01 · FY2020 · HL

Look AHEAD: Action for Health Diabetes

$1,094,228
F. Xavier Pi-Sunyer · St. Luke'S-Roosevelt Inst For Hlth Scis · U01 · FY2010 · DK

Small Molecule Therapeutics for Renal Disease

$1,094,052
Prakash Narayan · Angion Biomedica Corporation · R44 · FY2010 · DK

Partnerships for Diabetes Related Disparities in Hawaii

$1,093,656
University Of Hawaii At Manoa · P20 · FY2003 · MD

Water Contaminants and Cardiovascular Risk: the Jackson Heart Study

$1,093,506
April P Carson · University Of Mississippi Med Ctr · R01 · FY2024 · HL

Inhibition Of Renal Injury

$1,092,242
Robert A Star · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

Multi-ethnic Multi-level Strategies and Behavioral Economics to Eliminate Hypertension Disparities in LA County.

$1,091,835
Arleen F Brown · University Of California Los Angeles · UH3 · FY2023 · HL

Phagocyte Crosstalk in the Balance of Inflammation & Cardiac Disease

$1,091,824
Edward Benjamin Thorp · Northwestern University At Chicago · R35 · FY2025 · HL

CardioPulmonary Vascular Biology COBRE

$1,091,583
Gaurav Choudhary · Ocean State Research Institute, Inc. · P30 · FY2023 · GM